BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients
Clinical trial NCT02051062 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT02051062
- Sponsor
- Emergent BioSolutions
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2028-07-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.